Mural Oncology's stock plummeted 57% after halting the Phase 3 ARTISTRY-7 trial for nemvaleukin alfa. Click here to read an ...

The Health Insurance Counseling and Advocacy Program will offer a free virtual presentation titled “Understanding Medicare” [ ...

GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...

GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.8 at the end of 2024 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...

As global markets grapple with fluctuating economic indicators and policy uncertainties, Asian tech stocks have shown resilience amid mixed performances across major indices. In this context, ...

The Trump Administration has implemented or proposed a broad range of tariffs, including on pharmaceuticals. Careful ...

The global pharmaceutical packaging market accounted for $ 88,880 million in 2019, and is expected to reach $ 144,233 million by 2027, registering a CAGR of 6.1% from 2020 to 2027. The market is ...

CROSSJECT enhanced its collaboration with Eton Pharmaceuticals, Inc. ("Eton”) by providing its proprietary innovative hydrocortisone formulation (the "CROSSJECT Formulation”) to enter the hospital ...

The global infection control market was valued at $32,613.75 million in 2020, and is projected to reach $38,616.77 million by 2028, registering a CAGR of 3.0% from 2021 to 2028. The growth of the ...

CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) ("TOI” or the "Company”), one ...

MMS, an award-winning, data-focused clinical research organization (CRO), is showcasing its expansion as a tech-enabled, full-service Risk Evaluation and Mitigation Strategies (REMS) solutions ...